Loading clinical trials...
Loading clinical trials...
Improvement in Gross Motor Function and Muscle Tone in Children With Cerebral Palsy Related to Neonatal Icterus: An Open-label, Uncontrolled Clinical Trial
The purpose of this study is to evaluate the safety and effectiveness of stem cells for cerebral palsy related to neonatal icterus
The purpose of this study is to evaluate the safety and effectiveness of autologous bone marrow mononuclear stem cells in 25 patients with cerebral palsy related to neonatal icterus at Vinmec International Hospital, Hanoi, Vietnam
Age
1 - 15 years
Sex
ALL
Healthy Volunteers
No
Vinmec Research Institute of Stem Cell and Gene Technology
Hanoi, Vietnam
Start Date
April 1, 2014
Primary Completion Date
September 30, 2016
Completion Date
October 31, 2016
Last Updated
December 26, 2017
25
ACTUAL participants
Stem cell transplantation
COMBINATION_PRODUCT
Lead Sponsor
Vinmec Research Institute of Stem Cell and Gene Technology
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT07168577